Moreover, it is known that pre-invasive lesions, such as DCIS, are common in BRCA-associated breast cancers [18] and that in high-risk women with DCIS, the prevalence of a BRCA1/2 mutation is high [19]. This evidence concerns the gene BRCA1 and ductal breast carcinoma in situ.